The role of Denosumab, the RANKL inhibitor, on inflammatory response and gut microbiome dysbiosis as a result of DNBS-induced model of Crohn's disease. mouse gut metagenome
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
To investigate the role of Denosumab, the RANKL inhibitor, on inflammatory response and gut microbiome dysbiosis as a result of DNBS-induced model of Crohn's disease
创建时间：
2017-08-23
